Lindqvist; Ann-Margret

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lindqvist; Ann-Margret.The latest application filed is for "ibat inhibitors for treatment of metabolic disorders and related conditions".

Company Profile

0.3.8

Lindqvist; Ann-Margret - Askim SE
Lindqvist; Ann-Margret - Molndal SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ibat Inhibitors For Treatment Of Metabolic Disorders And Related Conditions App 20120114588 - Starke; Ingemar ; et al.	2012-05-10
Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity Grant 7,871,998 - Alenfalk , et al. January 18, 2	2011-01-18
2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia Grant 7,863,265 - Alenfalk , et al. January 4, 2	2011-01-04
Novel 2-Azetidinone Derivatives And Their Use As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemia App 20100216759 - Alenfalk; Susanne ; et al.	2010-08-26
Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity App 20100099657 - Alenfalk; Susanne ; et al.	2010-04-22
Diphenylazetidinone derivatives for treating disorders of the lipid metabolism Grant 7,470,678 - Starke , et al. December 30, 2	2008-12-30
Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity App 20080064676 - Alenfalk; Susanne ; et al.	2008-03-13
Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity App 20070142304 - Alenfalk; Susanne ; et al.	2007-06-21
Diphenylazetidinone derivatives for treating disorders of the lipid metabolism App 20050239766 - Starke, Ingemar ; et al.	2005-10-27
Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia App 20050124557 - Lindqvist, Ann-Margret	2005-06-09
Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor App 20050101611 - Starke, Ingemar ; et al.	2005-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.